Economic burden of antibiotic resistance: how much do we really know?

被引：175

作者：

Gandra, S. ^{[1
]}

Barter, D. M. ^{[1
]}

Laxminarayan, R. ^{[1
,2
,3
]}

机构：

[1] Ctr Dis Dynam Econ & Policy, Washington, DC USA

[2] Publ Hlth Fdn India, New Delhi 110017, India

[3] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA

来源：

CLINICAL MICROBIOLOGY AND INFECTION | 2014年 / 20卷 / 10期

基金：

比尔及梅琳达.盖茨基金会;

关键词：

Antibiotic resistance; attributable morbidity and mortality; economics; LENGTH-OF-STAY; SUSCEPTIBLE STAPHYLOCOCCUS-AUREUS; SPECTRUM BETA-LACTAMASES; BLOOD-STREAM INFECTIONS; TIME-DEPENDENT BIAS; NOSOCOMIAL METHICILLIN-RESISTANT; ANTIMICROBIAL RESISTANCE; HEALTH-CARE; ACINETOBACTER-BAUMANNII; HOSPITAL STAY;

D O I：

10.1111/1469-0691.12798

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

The declining effectiveness of antibiotics imposes potentially large health and economic burdens on societies. Quantifying the economic outcomes of antibiotic resistance effectively can help policy-makers and healthcare professionals to set priorities, but determining the actual effect of antibiotic resistance on clinical outcomes is a necessary first step. In this article, we review and discuss the contributions and limitations of studies that estimate the disease burden attributable to antibiotic resistance and studies that estimate the economic burden of resistance. We also consider other factors that are important in a comprehensive approach to evaluating the economic burden of antibiotic resistance.

引用

页码：973 / 980

页数：8

共 50 条

[21] What do we know and how do we really know it?
Pearce, JL
ACADEMY OF MANAGEMENT REVIEW, 2004, 29 (02): : 175 - 179
[22] HOW MUCH DO WE KNOW
FLORY, PJ
SPE TRANSACTIONS, 1964, 4 (01): : 5 - 6
[23] HOW MUCH DO WE REALLY KNOW ABOUT THE STRUCTURE OF AMORPHOUS SOLIDS
WRIGHT, AC
JOURNAL OF NON-CRYSTALLINE SOLIDS, 1985, 75 (1-3) : 15 - 27
[24] Risks of Epilepsy During Pregnancy How Much Do We Really Know?
French, Jacqueline A.
Meador, Kimford
JAMA NEUROLOGY, 2015, 72 (09) : 973 - 974
[25] The Physiology of Bone Pain. How Much Do We Really Know?
Nencini, Sara
Ivanusic, Jason J.
FRONTIERS IN PHYSIOLOGY, 2016, 7
[26] How much do we really know about postobstructive pulmonary oedema?
Yemen, TA
PAEDIATRIC ANAESTHESIA, 2000, 10 (05): : 459 - 461
[27] How Much Do We Really Know About Statins and Transplant Vasculopathy?
Harken, Alden H.
WORLD JOURNAL OF SURGERY, 2014, 38 (09) : 2335 - 2336
[28] QUALITY OF LIFE IN RHEUMATOID ARTHRITIS: HOW MUCH DO WE REALLY KNOW?
Rolfe, F.
Kusel, J.
Brooks-Rooney, C.
Leonard, S. A.
VALUE IN HEALTH, 2013, 16 (03) : A226 - A226
[29] How Much Do We Really Know About Statins and Transplant Vasculopathy?
Alden H. Harken
World Journal of Surgery, 2014, 38 : 2335 - 2336
[30] The risks associated with GI endoscopy: how much do we really know?
Benjamin, Stanley B.
GASTROINTESTINAL ENDOSCOPY, 2007, 66 (01) : 35 - 36

← 1 2 3 4 5 →